Introduction
Approximately 170 million people worldwide are chronically infected by HCV, which can result in progressive hepatic injury and fibrosis, resulting in cirrhosis and end-stage liver diseases [1] . Egypt receives the highest prevalence of HCV worldwide (15%) [2] . In 2011 WHO, stat that Egypt has the highest prevalence in the world, which is 22% [3] .
Portal hypertension (PH), defined by a hepatic venous pressure gradient (HVPG) greater than 6 mmHg is a common complication of cirrhosis. The development of EV is a clinical manifestation of PH with a prevalence that can range from 40% to 80% in patients with cirrhosis. This prevalence increases progressively in relation to the severity of liver damage [4] .The clinical course of compensating cirrhosis classified according to presence of esophageal varices into compensating cirrhosis with absence (stage 1) or the presence of varices (stage 2) with significant morbidity and mortality rates in compensated cirrhotic patients with varices (stage 2) [5] .
Upper gastrointestinal bleeding (UGB) caused by rupture of gastric and mainly EV are the most dramatic complication of cirrhosis with a mortality rate of 17% to 57% to this kind of patients [6] . HVPG and endoscopy are current gold-standard techniques to assess portal hypertension and EV. However, its use is limited by their invasiveness and screening all patients with endoscopy to guide therapy may significantly increase the cost [7] .
Endoscopic screening of all patients with liver cirrhosis would result in a large number of unnecessary endoscopies and additional burden to endoscopy units [8] .
In Egypt, the management of patients with liver cirrhosis complicated by the interplay between clinical, economic, social, and cultural factors and the generally poor compliance to both follow-up and treatment strategies [9] .
Ideally, a method for identifying patients with EV should be simple, noninvasive, inexpensive, reproducible, accurate, and readily available; have high sensitivity and specificity; follow the natural history; reflect the effect of the treatment accurately; and indicate the prognosis and possibility of success of a treatment [7] .
The aim of this study was to evaluate the validity of three non-invasive parameters in the prediction of esophageal
Patients
This study included 100 non-diabetic, non-obese patients with Child A HCV +ve cirrhosis who were under investigation and/or treatment in outpatient clinics, or patients referred to the hospital endoscopy unit for endoscopic screening for the presence of oesophageal varices. All patients signed informed consent before participating in this study.
Inclusion Criteria
Patients were included after they had a diagnosis of HCV +ve cirrhosis based on histopathological examination of liver biopsy whenever available or clinical criteria based on (history, physical examination, laboratory parameters and imaging findings) [5] . 
Exclusion Criteria

Statistical Analysis
All statistical calculations were performed using computer 
Results
This study comprised 100 patients with Child A HCV +ve cirrhosis, 40 patients were included after they had been diagnosed as cirrhosis based on histopathological examination of liver biopsy, 60 patients were included after they had been diagnosed as cirrhosis based on history, physical examination, biochemical parameters, ultrasonographic finding and Fibroscan. Table 3, Table 4 and Table 5 Table 8 Variable Analysis of data Β Coefficient ± Standard Error (SE) Table ( 9) shows that, when we compared the mean values of HOMA-IR score, platelet count/spleen diameter ratio between pateints with no varices and pateints with different grades of varices highly significance were noted with (P < 0.001), and when we compared the mean values of right liver lobe diameter /albumin ratio between pateints with no varices and pateints with different grades of varices also, significance were noted with (P = 0.003). 
HOMA-IR: Homeostasis Model Assessment of Insulin Resistance
( Figure 5) shows that, among the 3 non-invasive predictors, the HOMA-IR score gave the highest accuracy at a cut-off value of 3. The next highest accuracy was the platelet count/spleen diameter ratio at a cut-off value of 750. The least accurate of the 3 non-invasive predictors was right liver lobe diameter /albumin ratio at a cut-off value of 3.5.
Discussion
Because of the impact of UGB caused by rupture of EV in the prognosis of cirrhotic patients, the This study was conducted on 100 non-diabetic, non-obese patients with Child A HCV induced cirrhosis with forty patient had a diagnosis of HCV induced cirrhosis based on histopathological examination of liver biopsy and sixty patient had a diagnosis of cirrhosis based on physical findings, laboratory investigations, and ultrasonographic findings because of absence of liver biopsy.
In this study, the prevalence of EV in Child A HCV +ve cirrhosis were high, as 79 patients had esophageal varices (79%), 9 of them had also gastric varices. In this study, as well, the tested three parameters with high HOMA-IR score, low platelet count/spleen diameter ratio and high right liver lobe diameter /albumin ratio were all also associated with the presence and grade of varices. 
Garcia
Giannini et al., (2003)
introduced the use of the platelet count/spleen diameter ratio as a tool to predict oesophageal varices. This ratio links thrombocytopenia to splenomegaly to introduce a variable that takes into consideration that thrombocytopenia is mainly due to hypersplenism secondary to portal hypertension. In that study, when a cut-off value of 909 used, the sensitivity was 100%, and the specificity was 93% [29].
Giannini et al., (2006)
reported the results of a multicentre study to validate the use of platelet count/spleen diameter ratio in the prediction of esophageal varices. At a cut-off value of 909, the sensitivity was 92%, and the specificity was 67% Patient having the ratio greater than cut-off value should not receive nonselective beta-blockers prophylactic therapy because they are less likely to develop esophageal varices. These patients should less frequently undergo endoscopy.
Several studies have been performed using different best cut-off values to investigate this parameter as a noninvasive predictor for esophageal varices.
Agha et al., (2009) studied 114 patients with compensated
HCV related cirrhotics, 909 cut-off showed negative predictive value 100% and a positive predictive value of 93.8% for the diagnosis of EV.
Camma` et al., (2009) studied 104 newly diagnosed patients with Child A HCV +ve cirrhosis, identified a value of 792 as the best cutoff for the presence of esophageal varices and ratio greater than 792 Could be useful to identify patients at low risk of EV. and stated That different results are perhaps related to differences in etiology and class of disease between the two populations as regard Giannini et al study.
One study on Egyptian patients (Esmat et al., 2012) concluded that a cut-off value of 1326.58 for the platelet count/spleen diameter ratio was used with a resulting 96.34% sensitivity, 83.33% specificity and 94% accuracy.
In another study also done on Egyptian patients (Abu El Makarem et al., 2011) concluded that a cut-off value of 939.7 for the platelet count/spleen diameter ratio was used with a resulting 100% sensitivity, 86.3% specificity and 96.5% accuracy. In this study, the cut-off value of the platelet count/spleen diameter ratio (750) was the optimal value for accurate prediction of EV with a resulting 81% sensitivity, 81% specificity and 81% accuracy.
When we applied the same cut-off value of 909 Giannini used for the platelet count/spleen diameter ratio to the current study, the sensitivity and accuracy was significantly reduced to 65% and 73%, respectively.
The differences between the best cut-off values, sensitivity, specificity, and accuracy in this study and other studies may be attributed to several factors influencing the platelet count including infection, bleeding, drugs, and lower thrombopoietin levels in patients with liver cirrhosis. In addition, the absence of interobserver agreement between the sonographers and endoscopists of the different studies which can affect the results.
Regarding the right liver lobe diameter /serum albumin ratio Alempijevic et al., (2007) had counted an original ratio. For the first time they reported the value of the right liver lobe diameter /serum albumin concentration in assessment of portal hypertension. They used serum albumin concentration as a parameter of liver function in combination with right liver lobe size and used this ratio as a non-invasive predictor of esophageal varices with at a cut-off value of 4.425, the sensitivity was 83.1%, and the specificity was 73.9% .
In another study on Egyptian patients Esmat et al.,( 2012)
concluded that a cut-off value of 4.422 for the right liver lobe diameter/albumin concentration ratio gave sensitivity 91.46%, and the specificity 77.78% .
In this study, the cut-off value for the right liver lobe diameter/albumin concentration ratio (3.5) was the optimal value for accurate prediction of EVs with a resulting 78.5 % sensitivity, 57.1 % specificity, and 74 % accuracy.
The results of this study are the same results of other study on Egyptian patients done by (Adel and George, 2011). They investigate the right liver lobe diameter/albumin concentration ratio as a non-invasive predictor of esophageal varices, with the best cut off value at 3.5 where sensitivity was 80 % and specificity was 70 % .
When we applied the same cut of value of 4.425 roported by Alempijevic et al.,(2007) used for the right liver lobe diameter/albumin ratio to the current study, the sensitivity, and accuracy was significantly reduced to 12.7 % and 31%, respectively. The differences between the best cut-off values, sensitivity, specificity, and accuracy in this study and Alempijevic study may be attributed to the different group of patient as all patients in this study were child A with the mean albumin concentration (3.87 ± 0.4) but In the other study, the patients were child A, B and C with the mean albumin concentration (3.08± 0.8), also patients were have different ethnic background. In addition, the differences between the sonographers of different studies, which can affect the results. This suggests the need for further multicenter studies including a large number of patients with different ethnic background for determining the best cut-off, value for that ratio. Eslam et al., (2013), also concluded that in patients with cirrhosis, the presence of esophageal varices was independently associated with lower platelet count and raised HOMA score with HOMA score correlates with HVPG and independently predict clinical outcomes in these patients .
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In this study, the cut-off value for HOMA-IR score of greater than 3 was the optimal value for accurate prediction of EV with a resulting 88.6 % sensitivity, 95.2 % specificity, and 90 % accuracy.
When we applied the same cut-off value of 3.5 that Camma` et al used for the HOMA-IR score to this study, the sensitivity and accuracy was reduced to 65 % and 73% respectively. The differences between the best cut-off values, sensitivity, specificity, and accuracy in this study and Camma` et al study may be attributed to the different ethnic group of the patients, all patients in this study were non-diabetic and nonobese. Where in Camma` et al study 27 patients were diabetic and 11 patients were obese, and may be due to different genotype of HCV in studied groups where genotype 1 predominate Camma` et al study and genotype 4 mostly predominate our study.
The limitations of the present study includes: relatively small number of patients, liver biopsy was not done in all patient and the diagnosis of cirrhosis was based on clinical, laboratory results and imaging findings in sixty patients.
On conclusion, insulin resistance measured by HOMA-IR, Platelet count/Spleen diameter ratio, as well as the right liver lobe diameter/Albumin ratio are non-invasive parameters that can predict the presence and grade of esophageal varices in patients with Child A HCV +ve cirrhosis.
The HOMA-IR score gave the highest accuracy (90%) at a cut-off value of 3 with (sensitivity 88.6 % and specificity 95.2%). The next highest accuracy was the platelet count/spleen diameter ratio (81%) at a cut-off value of 750 with (sensitivity 81% and specificity 81%). The least accurate of the 3 non-invasive parameters was right liver lobe diameter /albumin ratio (74%) at a cut-off value of 3.5 with (sensitivity 78.5% and specificity 57.1%).
This is of a value to reserve endoscopy for only those patients who have a high probability of having varices, particularly in Egypt where the resources are limited and where endoscopy is not available in all areas.
Recommendations
Additional studies are required in a larger sample of Child A HCV-related liver cirrhosis patients for validation of these parameters as noninvasive predictors of oesophageal varices. In addition, those studies are necessary to determine a universal best cut-off values that can be safely recommended for the non-invasive diagnosis of oesophageal varices in these patients. 
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